Project Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

Pharmacotherapy of pervasive developmental disorders  

Pervasive developmental disorder-not otherwise specified (PDD NOS) is a highly prevalent disorder often associated with severe irritability that impedes participation in educational, therapeutic, and vocational programs, with escalating costs of care. Thus, the development of safe and effective pharmacotherapies that improve irritability is clearly relevant to public health. The investigator will conduct a double-blind, placebo-controlled and open-label continuation study of aripiprazole for irritability in 60 children and adolescents with PDD NOS.


Funder National Institutes of Health
Fiscal Year Funding $184,202.00
Project Number K23MH082119-01A1
Principal Investigator Stigler, Kimberly
Strategic Plan Question Question 4: Which Treatments And Interventions Will Help? (Interventions)
Strategic Plan Objective 4O. Not specific to Question 4 objectives
Federal or Private? Federal
Institution Indiana University-Purdue University at Indianapolis
State/Country Indiana
Web Link 1 No URL available.
Web Link 2 No URL available.
Web Link 3 No URL available.
History/Related Projects Pharmacotherapy of pervasive developmental disorders | $184,587.00 | 2010 | 5K23MH082119-03
Pharmacotherapy of pervasive developmental disorders | $184,259.00 | 2009 | 5K23MH082119-02